Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Akihiro Yachie »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Akihiro Tsuchimoto < Akihiro Yachie < Akihiro Yamada  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000198 (2020) Hitoshi Irabu [Japon] ; Masaki Shimizu [Japon] ; Shuya Kaneko [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
000542 (2019) Mao Mizuta [Japon] ; Masaki Shimizu [Japon] ; Natsumi Inoue [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome.
000691 (2018) Naoto Sakumura [Japon] ; Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Natsumi Inoue [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
000890 (2018) Motohiko Aizu [Japon] ; Ichiro Mizushima [Japon] ; Satoshi Nakazaki [Japon] ; Akikatsu Nakashima [Japon] ; Takashi Kato [Japon] ; Takashi Murayama [Japon] ; Shinichi Kato [Japon] ; Yasuo Katsuki [Japon] ; Kunihiro Ogane [Japon] ; Hiroshi Fujii [Japon] ; Kazunori Yamada [Japon] ; Hideki Nomura [Japon] ; Akihiro Yachie [Japon] ; Masakazu Yamagishi [Japon] ; Mitsuhiro Kawano [Japon]Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis.
000B18 (2017) Masaki Shimizu [Japon] ; Yasuo Nakagishi [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Akihiro Yachie [Japon]Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
001014 (2015) Masaki Shimizu [Japon] ; Yasuhito Hamaguchi [Japon] ; Sayaka Ishikawa [Japon] ; Kazuyuki Ueno [Japon] ; Akihiro Yachie [Japon]Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis.
001262 (2014) Ikuko Kubokawa [Japon] ; Akihiro Yachie ; Akira Hayakawa ; Satoshi Hirase ; Nobuyuki Yamamoto ; Takeshi Mori ; Tomoko Yanai ; Yasuhiro Takeshima ; Eiryu Kyo ; Goichi Kageyama ; Hiroshi Nagai ; Keiichiro Uehara ; Masaru Kojima ; Kazumoto IijimaThe first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
001667 (2012) Masaki Shimizu [Japon] ; Yasuo Nakagishi ; Kazuko Kasai ; Yuichi Yamasaki ; Mari Miyoshi ; Syuji Takei ; Akihiro YachieTocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.
001721 (2012) Masaki Shimizu [Japon] ; Kazuyuki Ueno ; Akihiro YachieRelapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Akihiro Yachie" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Akihiro Yachie" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Akihiro Yachie
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021